Cartesian Therapeutics' lead asset, Descartes-08, demonstrated a 7.1-point MG-ADL reduction at 12 months in Phase 2b. Find ...
ServiceNow (NOW) shares plummeted 14% during early post-market trading on Wednesday after the enterprise software firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results